Influenza Prevention in Facilities

A team of nationally recognized long-term care researchers from Brown University and Insight Therapeutics are undertaking a large-scale quality improvement study to evaluate the impact of the annual influenza vaccine choice on long-term care facility residents’ hositalization risk for the 2019-2010 influenza season.

Nursing homes that meet eligibility and agree to participate will be allocated to one of two CDC-recommended influenza vaccines for adults. Nursing homes will receive a supply of vaccine for all nursing home residents and staff at no cost and add to the body of knowledge about influenza prevention in the frail nursing home population.

Please visit the study page at Insight Therapeutics website for more information.

Leave a Reply

Your email address will not be published. Required fields are marked *

Michigan NADONA